This trial is testing a new cancer drug to see if it works well and what the side effects are.
2 Primary · 1 Secondary · Reporting Duration: 63 days
Experimental Treatment
120 Total Participants · 10 Treatment Groups
Primary Treatment: ONC201 · No Placebo Group · Phase 1 & 2
Age 18+ · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: